About Gene Techno Science
Gene Techno Science is a publicly listed company based in Tokyo (Japan) founded in 2001. Developer of antibodies for the treatment of autoimmune and bone diseases. Its focus areas include Life Sciences, Immunotherapy, Antibody and Disease-Targeting.
Company details
Gene Techno Science was founded in 2001 and is based in Tokyo, Japan. Operations focus on the biotechnology sector, where antibodies targeting integrin alpha are developed for treating autoimmune and bone diseases. These antibodies are currently undergoing pre-clinical trials. The companys domain is g-gts.com, supporting its research and development activities in this specialized field.
- Latest Funding Round$2.71M (USD), Post-IPO
Mar 2017
Funding Insights of Gene Techno Science
- Total Rounds 1
- Last Round Post-IPO — $2.71M
- First Round $2.71M
(Mar 2017)
All 1 funding rounds of Gene Techno Science with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | $2.71M | Post-IPO | – | – | – |
IPO & Listings of Gene Techno Science
Gene Techno Science is a publicly listed company on the TSE with ticker symbol 4584 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Nov 2012
- Listed onTSE: 4584
- Listed entityKidswell Bio Corporation
- Exchange sectorHealth technology
Timeline of Gene Techno Science
3 dated milestones of Gene Techno Science across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Gene Techno Science is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $2.7M.
Web traffic of Gene Techno Science
Websites that share an audience with Gene Techno Science (g-gts.com).
Websites whose visitors overlap most with Gene Techno Science. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| chiome.co.jp | 100% | 7.1K | #2,745,679 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gene Techno Science
Complete news archive for Gene Techno Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gene Techno Science
Gene Techno Science was founded in 2001 and raised its 1st funding round 16 years after it was founded.
Gene Techno Science is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Gene Techno Science was founded in 2001 and is based in Tokyo, Japan. Operations focus on the biotechnology sector, where antibodies targeting integrin alpha are developed for treating autoimmune and bone diseases. These antibodies are currently undergoing pre-clinical trials. The companys domain is g-gts.com, supporting its research and development activities in this specialized field.
Yes, Gene Techno Science is publicly traded on TSE under the ticker symbol 4584.